| Year |
Citation |
Score |
| 2023 |
Yu Q, Kobayashi SS, Haeno H. Mathematical analysis identifies the optimal treatment strategy for epidermal growth factor receptor-mutated non-small cell lung cancer. Frontiers in Oncology. 13: 1137966. PMID 37841421 DOI: 10.3389/fonc.2023.1137966 |
0.309 |
|
| 2021 |
Takaki M, Haeno H. Mathematical Modeling of Locoregional Recurrence Caused by Premalignant Lesions Formed Before Initial Treatment. Frontiers in Oncology. 11: 743328. PMID 34722296 DOI: 10.3389/fonc.2021.743328 |
0.412 |
|
| 2019 |
Mizukoshi K, Okazawa Y, Haeno H, Koyama Y, Sulidan K, Komiyama H, Saeki H, Ohtsuji N, Ito Y, Kojima Y, Goto M, Habu S, Hino O, Sakamoto K, Orimo A. Metastatic seeding of human colon cancer cell clusters expressing the hybrid epithelial/mesenchymal state. International Journal of Cancer. PMID 31506938 DOI: 10.1002/Ijc.32672 |
0.368 |
|
| 2019 |
Mimaki S, Watanabe M, Kinoshita M, Yamashita R, Haeno H, Takemura S, Tanaka S, Marubashi S, Totsuka Y, Shibata T, Nakagama H, Ochiai A, Nakamori S, Kubo S, Tsuchihara K. Multifocal origin of occupational cholangiocarcinoma revealed by comparison of multilesion mutational profiles. Carcinogenesis. PMID 31228243 DOI: 10.1093/Carcin/Bgz120 |
0.328 |
|
| 2019 |
Yamamoto KN, Nakamura A, Liu LL, Stein S, Tramontano AC, Kartoun U, Shimizu T, Inoue Y, Asakuma M, Haeno H, Kong CY, Uchiyama K, Gonen M, Hur C, Michor F. Computational modeling of pancreatic cancer patients receiving FOLFIRINOX and gemcitabine-based therapies identifies optimum intervention strategies. Plos One. 14: e0215409. PMID 31026288 DOI: 10.1371/Journal.Pone.0215409 |
0.35 |
|
| 2019 |
Yamamoto KN, Liu LL, Nakamura A, Haeno H, Michor F. Stochastic Evolution of Pancreatic Cancer Metastases During Logistic Clonal Expansion. Jco Clinical Cancer Informatics. 1-11. PMID 30901235 DOI: 10.1200/CCI.18.00079 |
0.371 |
|
| 2019 |
Aoki K, Yamamoto T, Suzuki H, Maeda S, Ranjit M, Motomura K, Nakamura H, Narita Y, Nakada M, Deguchi S, Mizoguchi M, Momii Y, Muragaki Y, Abe T, Akimoto J, ... ... Haeno H, et al. TMOD-33. AN INTEGRATED APPROACH COMBINING MATHEMATICAL AND GENOMIC METHODS TO REVEAL THE OPTIMAL TIMING OF THERAPEUTIC INTERVENTION IN WHO GRADE II DIFFUSE GLIOMA Neuro-Oncology. 21: vi270-vi270. DOI: 10.1093/Neuonc/Noz175.1132 |
0.428 |
|
| 2018 |
Stein S, Zhao R, Haeno H, Vivanco I, Michor F. Mathematical modeling identifies optimum lapatinib dosing schedules for the treatment of glioblastoma patients. Plos Computational Biology. 14: e1005924. PMID 29293494 DOI: 10.1371/Journal.Pcbi.1005924 |
0.407 |
|
| 2017 |
Yamamoto KN, Yachida S, Nakamura A, Niida A, Oshima M, De S, Rosati LM, Herman JM, Iacobuzio-Donahue CA, Haeno H. Personalized Management of Pancreatic Ductal Adenocarcinoma Patients Through Computational Modeling. Cancer Research. PMID 28381541 DOI: 10.1158/0008-5472.Can-16-1208 |
0.372 |
|
| 2016 |
Uchi R, Takahashi Y, Niida A, Shimamura T, Hirata H, Sugimachi K, Sawada G, Iwaya T, Kurashige J, Shinden Y, Iguchi T, Eguchi H, Chiba K, Shiraishi Y, Nagae G, ... ... Haeno H, et al. Integrated Multiregional Analysis Proposing a New Model of Colorectal Cancer Evolution. Plos Genetics. 12: e1005778. PMID 26890883 DOI: 10.1371/Journal.Pgen.1005778 |
0.421 |
|
| 2015 |
Yamamoto KN, Nakamura A, Haeno H. The evolution of tumor metastasis during clonal expansion with alterations in metastasis driver genes. Scientific Reports. 5: 15886. PMID 26515895 DOI: 10.1038/Srep15886 |
0.429 |
|
| 2014 |
Yamamoto KN, Hirota K, Takeda S, Haeno H. Evolution of pre-existing versus acquired resistance to platinum drugs and PARP inhibitors in BRCA-associated cancers. Plos One. 9: e105724. PMID 25158060 DOI: 10.1371/Journal.Pone.0105724 |
0.448 |
|
| 2013 |
Haeno H, Maruvka YE, Iwasa Y, Michor F. Stochastic Tunneling of Two Mutations in a Population of Cancer Cells. Plos One. 8: e65724. PMID 23840359 DOI: 10.1371/Journal.Pone.0065724 |
0.544 |
|
| 2012 |
Iwami S, Haeno H, Michor F. A race between tumor immunoescape and genome maintenance selects for optimum levels of (epi)genetic instability. Plos Computational Biology. 8: e1002370. PMID 22359489 DOI: 10.1371/Journal.Pcbi.1002370 |
0.419 |
|
| 2012 |
Haeno H, Gonen M, Davis MB, Herman JM, Iacobuzio-Donahue CA, Michor F. Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies. Cell. 148: 362-75. PMID 22265421 DOI: 10.1016/J.Cell.2011.11.060 |
0.416 |
|
| 2012 |
Haeno H, Gonen M, Davis MB, Herman JM, Iacobuzio-Donahue CA, Michor F. Abstract 3961: Computational modeling of pancreatic cancer reveals growth and dissemination kinetics and suggests optimum treatment strategies Cancer Research. 72: 3961-3961. DOI: 10.1158/1538-7445.Am2012-3961 |
0.407 |
|
| 2011 |
Hambardzumyan D, Cheng YK, Haeno H, Holland EC, Michor F. The probable cell of origin of NF1- and PDGF-driven glioblastomas. Plos One. 6: e24454. PMID 21931722 DOI: 10.1371/Journal.Pone.0024454 |
0.413 |
|
| 2011 |
Klinakis A, Lobry C, Abdel-Wahab O, Oh P, Haeno H, Buonamici S, van De Walle I, Cathelin S, Trimarchi T, Araldi E, Liu C, Ibrahim S, Beran M, Zavadil J, Efstratiadis A, et al. A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia. Nature. 473: 230-3. PMID 21562564 DOI: 10.1038/Nature09999 |
0.332 |
|
| 2010 |
Haeno H, Michor F. The evolution of tumor metastases during clonal expansion. Journal of Theoretical Biology. 263: 30-44. PMID 19917298 DOI: 10.1016/J.Jtbi.2009.11.005 |
0.449 |
|
| 2009 |
Haeno H, Levine RL, Gilliland DG, Michor F. A progenitor cell origin of myeloid malignancies. Proceedings of the National Academy of Sciences of the United States of America. 106: 16616-21. PMID 19805346 DOI: 10.1073/Pnas.0908107106 |
0.463 |
|
| 2007 |
Haeno H, Iwasa Y, Michor F. The evolution of two mutations during clonal expansion. Genetics. 177: 2209-21. PMID 18073428 DOI: 10.1534/Genetics.107.078915 |
0.552 |
|
| 2007 |
Haeno H, Iwasa Y. Probability of resistance evolution for exponentially growing virus in the host. Journal of Theoretical Biology. 246: 323-31. PMID 17306832 DOI: 10.1016/J.Jtbi.2007.01.009 |
0.454 |
|
| Show low-probability matches. |